Actinium Pharmaceuticals Stock Forecast

Sell candidate since Jun 12, 2026 Gain 0.99%

The Actinium Pharmaceuticals, Inc stock price fell by -0.97% on the last day (Tuesday, 23rd Jun 2026) from $1.03 to $1.02. During the last trading day the stock fluctuated 3.96% from a day low at $1.01 to a day high of $1.05. The price has fallen in 6 of the last 10 days and is down by -3.77% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -32 thousand shares and in total, 39 thousand shares were bought and sold for approximately $39.55 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.98 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -3.93% during the next 3 months and, with a 90% probability hold a price between $0.94 and $1.42 at the end of this 3-month period.

ATNM Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 4.08%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Actinium Pharmaceuticals, Inc stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.15. On a fall, the stock will find some support from the short-term average at $1.01. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Actinium Pharmaceuticals, Inc stock

Actinium Pharmaceuticals, Inc finds support from accumulated volume at $1.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0400 between high and low, or 3.96%. For the last week the stock has had daily average volatility of 5.57%.

Actinium Pharmaceuticals, Inc is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATNM) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Actinium Pharmaceuticals, Inc to open at $1.03, and during the day (based on 14 day Average True Range), to move between $0.99 and $1.05, which gives a possible trading interval of +/-$0.0641 (+/-6.48%) up or down from last closing price. If Actinium Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 6.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.01 (0.98%) than the resistance at $1.11 (8.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Actinium Pharmaceuticals, Inc stock A Buy?

Actinium Pharmaceuticals, Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.947 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $1.03 ( 0.654%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk